New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data show

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis—a dangerous, disease-induced build-up of scar tissue…

Continue Reading

News Source: medicalxpress.com